Navigation Links
Novel export-inhibitor shows promise for treating CLL
Date:12/12/2011

An experimental drug that works by blocking the export of key control molecules from the nucleus of cancer cells shows promise as a treatment for chronic lymphocytic leukemia (CLL) and other incurable B-cell malignancies, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James).

The agent, called KPT-SINE, belongs to a new class of drugs called selective inhibitors of nuclear export (SINE). The agent was developed by Karyopharm Therapeutics Inc. It is designed to kill cancer cells by restoring biochemical pathways that normally cause unhealthy cells to self-destruct through a process called programmed cell death, or apoptosis.

The agent targets a protein called CRM1, which, until now, has not been adequately explored in CLL, the researchers say. During disease progression, cancer cells use CRM1 to shunt certain apoptosis-related proteins out of the nucleus, thereby avoiding cell death.

"We believe that KPT-SINE and other nuclear-export inhibitors may represent a unique, entirely new therapeutic strategy for treating cancer by simultaneously restoring multiple normal cell death pathways," says OSUCCC James research scientist Dr. Rosa Lapalombella who is a co-investigator on the study with Dr. John Byrd, director of the division of hematology and co-director of the OSUCCC James CLL Experimental Therapeutics Laboratory at OSUCCC James.

The researchers hypothesize that KPT-SINE will inhibit CRM1 and keep these regulatory proteins in the nucleus where they can initiate programmed cell death.

Lapalombella will discuss the role of CRM1 inhibition in the treatment of CLL on Monday, December 12, at 7:00 a.m. during the 53rd Annual Meeting of the American Society of Hematology in San Diego, CA.

The study, which used CLL cells from patients and a mouse model of CLL, provides essential proof-of-concept data to desig
'/>"/>

Contact: Eileen Scahill
Eileen.Scahill@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Novel experimental agent is highly active in CLL patients, interim study shows
2. Researchers identify a novel therapeutic approach for liver cancer
3. Novel drug wipes out deadliest malaria parasite through starvation
4. Novel approach to treating breast cancer shows great promise
5. Wayne State receives $1.9 million from NIH to create novel cystic fibrosis treatments
6. Novel ALS drug slows symptom progression, reduces mortality in phase 2 trial
7. Wayne State University to study novel treatment for antibiotic-resistant bacteria
8. Novel, noninvasive measurement a strong predictor for heart failure in general population
9. UK HealthCare surgeons are first to perform novel procedures prior to transplant
10. Novel approach to treat proliferative vitreoretinopathy shows promise
11. Novel strategy stymies SARS et al.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 The birth control safety ... who have used the contraceptive NuvaRing. A new report ... clot injuries has increased in recent months*. , DrugRisk ... and devices with the latest safety alerts, recalls, studies ... are experiencing similar side effects and decide if they ...
(Date:5/20/2013)... 2013 USA Book News announced Monday ... Peak Performance" won the top honor in its 2013 ... over a multitude of international titles published from 2011-2013, ... acclaim from both mainstream and new age audiences looking ... and spiritually. , “The Infinity Zone” is ...
(Date:5/20/2013)... Texas (PRWEB) May 21, 2013 ... on product type into two categories - semi-automated ... market is classified into five categories, namely, hospitals, ... market is forecast till 2017. Automated external defibrillators ... of sudden cardiac arrest victims. Considering the life-saving ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Recent ... importance of using green and sustainable inputs in ... has implemented regulations to promote the use of ... Packaging and Labelling Services industry . “Tax subsidies ... trend,” says IBISWorld industry analyst Deonta Smith. “For ...
(Date:5/20/2013)... Florida (PRWEB) May 20, 2013 In order ... supplemental health and wellness team from DrSmartphoneMD launched an article ... serious sunburns. , The series launched with the ... that members of the DrSmartphoneMD program are not one of ... team explained that more than 90% of all skin cancer ...
Breaking Medicine News(10 mins):Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Combat Skin Cancer In Summer Months 2
... study shows that combining high resolution and high sensitivity ... emission computed tomography (SPECT) scans, said researchers at SNM,s ... rays so that only those traveling parallel to a ... it is not yet possible to focus radiation with ...
... skin patch can safely and successfully treat basal cell ... cancers, according to researchers at the SNM,s 56th Annual ... is nontoxic and could be an excellent alternative to ... treatments is difficult. "While basal cell carcinoma is ...
... pandemic level, a new article http://www.cmaj.ca/cgi/rapidpdf/cmaj.090866 in ... oseltamivir (Tamiflu) and zanamivir (Relenza) are relatively safe drugs ... women, especially those in the third trimester, are at ... influenza virus. The study was conducted by researchers ...
... , Brand unveils four-month awareness campaign featuring Len Dawson, Ken Griffey ... with ZERO - The Project to End Prostate Cancer , ... staggering one in six men and 192,000 men expected to be ... KMB ) and the Depend brand today announced a ...
... Insight built on SAP(R) BusinessObjects(TM) software , ... /PRNewswire/ -- Tata Consultancy Services (TCS) ... business solutions and outsourcing firm, has launched Provider ... on SAP(R) BusinessObjects(TM) software for hospitals and other ...
... stories and demands for solutions to lawmakers in Washington , ... , ATLANTA, June 15 As lawmakers wrangle over health reform ... one mom is making sure people,s voices are heard. Kathie McClure, ... states to expose the gaps in our tattered healthcare system safety ...
Cached Medicine News:Health News:New skin cancer patch: Possible alternative to surgery 2Health News:Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer' 2Health News:Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer' 3Health News:Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer' 4Health News:Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 2Health News:Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 3Health News:Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 4Health News:Mom on Mission for Quality, Affordable Healthcare for All Drives Purple Bus Across Nation Gathering Stories 2Health News:Mom on Mission for Quality, Affordable Healthcare for All Drives Purple Bus Across Nation Gathering Stories 3
(Date:5/20/2013)... Ill. , May 20, 2013 Landauer, ... in personal and environmental radiation measurement and monitoring, outsourced ... announced today that its Board of Directors declared, at ... cash dividend of $0.55 per share for the third ... on July 3, 2013, to shareholders of record on ...
(Date:5/20/2013)... May 20, 2013  Valeant Pharmaceuticals International, Inc. (NYSE: ... senior management team will make a presentation at the 34 ... 11, 2013 at 9:20 a.m. PT. The conference will be ... CA. A live webcast and audio ... Web site at www.valeant.com . Click on Investor Relations, ...
(Date:5/20/2013)... VIEW, Calif. , May 20, 2013 /PRNewswire-iReach/ ... results of the first study demonstrating detection of ... Yersinia pestis and Bacillus anthracis ... Control and Prevention,s list of potential bio-threats. This ... Science and Technology Laboratory, Salisbury ...
Breaking Medicine Technology:Landauer, Inc. Declares Regular Cash Dividend 2Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2
... April 18, 2011 Altitude Organic Corporation (Pinksheets: ... announced today that it has launched its third-party ... headquarters.  Visit the DoctorMMJ.com website ( www.DoctorMMJ.com ) ... and entirely legal medical marijuana evaluation in Arizona. ...
... 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ... Administration (FDA) has accepted for review the Company,s Biologics ... of the neovascular form of age-related macular degeneration (wet ... priority review of its BLA.  A Priority Review designation ...
Cached Medicine Technology:Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 2Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 3FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 2FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: